摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-carbonyl)-1,4-dioxa-8-aza-spiro[4.5]decane | 69663-59-8

中文名称
——
中文别名
——
英文名称
7-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-carbonyl)-1,4-dioxa-8-aza-spiro[4.5]decane
英文别名
1,4-dioxa-8-azaspiro[4.5]decan-8-yl(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyl)methanone
7-(10,11-dihydro-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cycloheptene-5-carbonyl)-1,4-dioxa-8-aza-spiro[4.5]decane化学式
CAS
69663-59-8
化学式
C23H25NO3
mdl
——
分子量
363.456
InChiKey
PEUFCFRLQSGHRQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.28
  • 重原子数:
    27.0
  • 可旋转键数:
    1.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    38.77
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    7-(10,11-dihydro-5H-dibenzo[a,d]cycloheptene-5-carbonyl)-1,4-dioxa-8-aza-spiro[4.5]decane氢化铝锂 生成 8-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylmethyl)-1,4-dioxa-8-azaspiro[4.5]decane
    参考文献:
    名称:
    KUKLA M. J.; BLOSS J. L.; BROUGHAM L. R., J. MED. CHEM., 1979, 22, NO 4, 401-406
    摘要:
    DOI:
  • 作为产物:
    参考文献:
    名称:
    Use of the butaclamol template in a search for antipsychotic agents with lessened side effects
    摘要:
    A number of molecular similarities between the antipsychotic agents butaclamol and clozapine were noted. Based on the premise that this was a strong indicator of a common mechanism of action (i.e., binding at the antagonist state of the dopamine receptor), a research approach was described. Three simplified analogues (4,8, and 12a) of butaclamol which still retained the molecular functionalities of the parent structure were synthesized and tested in the haloperidol receptor assay. 1-(5-Methyl-10, 11-dihydro-5H-dibenzo[a,d]cycloheptene)-4-tert-butyl-4-piperidine (12a) displaced tritiated haloperidol with an IC50 value of 2.4 nM, as compared to a value of 0.5 nM for butaclamol However, when 12a was tested in vivo or in the spiroperidol receptor assay it was found to be considerably less potent.
    DOI:
    10.1021/jm00190a009
点击查看最新优质反应信息